PATIENTS AND METHODS
The Beijing Tongren Eye Centre is one of the largest eye centers in China, with 480,000 outpatients served in 2006. Due to the location of Beijing, most of the patients originated from North China. For the purpose of the current study, the files for all patients in the Department of Ophthalmic Pathology between January 1997 and December 2006 were reviewed for those with an eyelid tumor. We retrieved the data of 2,733 eyelid neoplasms, of which 94 cases (3.1%) were excluded from the analysis because the histopathologic reexamination resulted in a diagnosis other than an eyelid neoplasm. The final study included 2,639 cases that were histopathologically reassessed and the data were used for the statistical analysis, which was performed by using a commercially available statistical software package (SPSS for Windows, version 11.5; SPSS, Inc., Chicago, IL).
RESULTS
In the study population, there were 1,134 (43.0%) males and 1,505 (57.0%) females. Of these eyelid neoplasms, 2,276 (86.2%) cases were benign and 363 (13.8%) cases were malignant or semi-malignant. The mean age ± standard deviation at the time of diagnosis was 41.3 ± 20.5 years for the benign lesions and 59.9 ± 13.9 years for the malignant or semi-malignant tumors. The difference of mean age between the two groups was statistically significant (P < .0001, t test). The male-tofemale ratio was significantly different between benign lesions and malignant or semi-malignant tumors (1:1.4 vs 1:1.1; P = .04, chi-square test) ( Table 1) .
In the group of benign lesions (n = 2,276 cases), the most common diseases were inflammatory lesions (n = 637 cases; 28.0%), melanocytic nevi (n = 466 cases; 20.5%) (Fig. 1) , papillomas (n = 307; 13.5%), dermoid and epidermoid cysts (n = 168; 7.4%) (Fig.  2) , and epithelial cysts (n = 135; 5.9%) ( Table 2 ). In the group of malignant or semi-malignant tumors (n = 363 cases), the most frequent lesions were basal cell carcinomas (n = 150; 41.3%) (Fig. 3) , sebaceous gland carcinomas (n = 140; 38.6%) (Fig. 4) , lymphomas (n = 33; 9.1%) (Fig. 5) , squamous cell carcinomas (n = 18; 5.0%) (Fig. 6) , and malignant melanomas (n = 16; 4.4%). The mean age ± standard deviation at the time of diagnosis was 61.1 ± 14.0 years for the patients with basal cell carcinoma, 61.1 ± 12.8 years for the patients with sebaceous gland carcinoma, 56.7 ± 17.0 years for the patients with squamous cell carcinoma, 51.9 ± 8.0 years for the patients with malignant melanoma, and 47.6 ± 20.4 years for the patients with lymphoma. The difference of gender ratio among the above five malignant or semi-malignant tumors was not statistically significant (P = .371, chi-square test) ( Table 3) . Comparing this study with Dai et al.'s study in China, 2 the relative frequencies of the five major malignant or semi-malignant tumors varied significantly between the two investigations (P < .0001, chi-square test) ( Table 4) .
DISCUSSION
In the spectrum of eyelid tumors, benign lesions generally account for a large percentage. In the current study, the benign lesions represented approximately 86% of cases, resulting in a ratio of benign lesions to malignant or semi-malignant lesions of approximately 6:1. In a previous study from the Beijing Tongren Hospital between 1961 and 1997, benign lesions accounted for 81.9% and malignant tumors accounted for the remaining 18.1%, 2 with a similar ratio of benign lesions to malignant or semi-malignant lesions as in the current study. It may suggest that the frequency of malignant or semi-malignant lesions may not have markedly increased over the past years. In 1996, Ni reported a series of eyelid tumors sampled during a 40-year period in the Shanghai Eye and Ear Hospital in China, in which the ratio of benign lesions to malignant lesions was 2:1, with a relatively high proportion of malignancies. 3 Reasons for the discrepancies between the two studies from Shanghai and Beijing may be differences in the composition of the benign lesion group. In the Shanghai study, the five most common benign tumors were papillomas, melanocytic nevi, cysts, angiomas, and verrucas; inflammatory lesions were not included. This may have markedly reduced the overall number of benign lesions in the study population, leading to an increase in the relative frequency of the non-benign lesions. In addition, differences between North and South China may have played a role. With respect to the benign lesions, both studies did not markedly vary, except that the inflammatory lesions were not counted at all in the Shanghai study.
2,3
The data of the current study can be compared with the results of a previous study by Dai et al. covering a study period from 1961 and 1997 from the same hospital. 2 Comparing the results of both studies reveals statistically significant variations in the spectrum of malignant eyelid tumors. In the current study, the five most common malignant or semi-malignant tumors were basal cell carcinoma, sebaceous gland carcinoma, lymphoma, squamous cell carcinoma, and melanoma, whereas in the study by Dai et al. the five most common malignant or semi-malignant tumors were basal cell carcinoma, sebaceous gland carcinoma, squamous cell carcinoma, melanoma, and lymphoma. 2 A study by Ni 3 in Shanghai obtained results similar to the Beijing study by Dai et al. 2 The relative increase in the frequency of eyelid lymphomas in the current investigation compared with the two other studies may be due to various reasons, including differences in the application of diagnostic techniques such as histochemistry, the referral of patients, the frequency of the underlying disease, environmental factors, awareness of health care, and others. 4 The results of studies about eyelid malignant tumors varied markedly in different parts of the world. Histopathologic spectrum and relative frequencies showed striking differences between countries. A study by Lin et al. revealed that the three most common tumors in the Taiwan region were basal cell carcinoma (65.1%), squamous cell carcinoma (12.6%), and sebaceous gland carcinoma (7.9%). 5 A study by Lee et al. revealed that the three most common lesions in Singapore were basal cell carcinoma (84.0%), sebaceous gland carcinoma (10.2%), and squamous cell carcinoma (3.4%). 6 A study by Sihota et al. revealed that the three most common le- sions in India were sebaceous gland carcinoma (32.6%), basal cell carcinoma (29.8%), and squamous cell carcinoma (28.1%). 7 A study by Cook and Bartley revealed that the three most common tumors in Minnesota were basal cell carcinoma (90.8%), squamous cell carcinoma (8.6%), and melanoma (0.6%). 8 In general, basal cell carcinoma is still the most common cancer of the eyelid, 9 which has been supported by most of the related studies. It accounts for 80% to 90% of all eyelid cancers in Western countries, 9 whereas in Japan and India it ranked second in eyelid cancers, accounting for 32.6% and 29.8% of all lesions, respectively. 7, 10 The mean age at diagnosis of the eyelid basal cell carcinoma was approximately 60 years. 11 In a similar manner, the mean age at diagnosis of basal cell carcinoma was 61 years in the current investigation. Two of 150 cases (1.3%) were patients who were younger than 30 years at the time of diagnosis. This may show that basal cell carcinoma can also occur in relatively young adults. These younger patients may have an inherited predisposition to cutaneous neoplasia.
Sebaceous gland carcinoma of the eyelid has been relatively common in Asians. 9 According to the current study, the study by Dai et al., 2 and the study by Ni, 3 the relative frequency of sebaceous gland carcinoma was high in China and only a little lower than that of basal cell carcinoma. Lin et al. reported that sebaceous gland carcinoma accounted for only 7.9% of the eyelid cancers in the Taiwan region, which was far lower than for basal cell carcinoma. 5 Lee et al. reported that sebaceous gland carcinoma constituted approximately 7.2% of eyelid cancers and was the second most common tumor in Singapore, whereas basal cell carcinoma had a relative frequency of 84.0%. 6 Sihota et al. showed that sebaceous gland carcinoma represented 32.6% of the eyelid malignancies in India. 7 However, in the study by Cook and Bartley there was no sebaceous gland carcinoma in eyelid malignancies in Minnesota. 8 The incidence of sebaceous gland carcinoma varies greatly in different countries, and it is believed to be race related and occur more commonly in Asians than in Europeans and Americans. 1, 9 It was reported previously that there was a predominance of sebaceous cell carcinoma in women. 12, 13 In Singapore, sebaceous cell carcinoma was found to be almost twice as common in females as in males. 6 Dai et al. reported that the male-to-female ratio of sebaceous gland carcinoma was 0.76:1, which showed that there were more female patients. 2 In the current study, the male-to-female ratio of sebaceous gland carcinoma was 1:1.1, and only a slight female predominance was shown. The average age at diagnosis has been cited as between 50 and 90 years of age. 14 The median age at diagnosis in the current study was 64 years.
The relative frequencies of squamous cell carcinoma in various studies showed that there was a wide variation, ranging from 2.4% in Philadelphia, Pennsylvania, to 48.1% in Kyushu, Japan. 10, 15 It is possible that the higher ratio reported may be due in part to the tendency to overdiagnose squamous cell carcinoma of the eyelid in the past as a result of its resemblance to other lesions. 16 Although it has been noted that this cancer is seen less frequently in individuals with dark skin, it is interesting to note that the proportion of squamous cell carcinoma was relatively high in India. 7, 17 In the current study, squamous cell carcinoma was found more frequently in males than in females, which was consistent with the studies by Dai et al. 2 and Sihota et al. 7 The median age of diagnosis of squamous cell carcinoma of the eyelid in the current study was 57 years, which was younger than the 65 years reported by Lee et al. 6 and the 72 years reported by Dailey et al. 18 Malignant melanoma constituted approximately 1% of all malignant neoplasms of the eyelid. 8, 9 Despite its relatively low frequency (approximately 3% of all skin cancers are malignant melanomas), malignant melanomas have a relatively poor prognosis: two-thirds of all deaths from skin cancer result from this tumor. 8, 9 In the current study, malignant melanomas accounted for 4.4% of all lesions and were found to be more than twice as common in females as in males (male:female ratio = 1:2.2).
Benign lesions in the current study accounted for a large percentage of eyelid neoplasms, whereas malignant tumors represented a smaller percentage and occurred predominantly in elderly patients 60 years and older. Basal cell carcinoma and sebaceous gland carcinoma were the most common malignant eyelid tumors and lymphomas ranked third. Comparing the current study with a previous investigation from the same hospital, no significant variation in the spectrum of the benign lesions was found, whereas significant variations in the histopathologic spectrum of the malignant tumors, particularly with respect to the frequency of lymphomas, were detected. Comparing the results of the current study from China with results of other investigations from different regions of the world, differences in the spectrum and relative frequency of eyelid malignancies were found, so ethnic background may have to be considered.
